Regeneron
Latest
FACTBOX-Front runners in development of antibody drugs against COVID-19
AstraZeneca, Eli Lilly, Regeneron and GlaxoSmithKline are among the biggest pharmaceutical companies to have developed COVID-19 treatments using a class of drugs called monoclonal antibodies, but the spread of the…
Europe secures 55,000 doses of Roche-Regeneron COVID drug hope
The European Union has secured about 55,000 doses of a potential treatment for COVID-19 based on a cocktail of monoclonal antibodies developed…
Regeneron’s COVID-19 cocktail helps prevent symptomatic disease – study
Regeneron's COVID-19 antibody cocktail helped cut the risk of symptomatic infections by 81% among people in households where another member had become…
EU regulator endorses Regeneron antibody cocktail to treat COVID-19
Europe's medicines regulator said on Friday an antibody drug combination developed by Regeneron Pharmaceuticals can be used to treat COVID-19 patients who…
U.S. FDA grants emergency use authorisation COVID-19 antibody given to Trump
The U.S. Food and Drug Administration on Saturday issued emergency use authorization for Regeneron Pharmaceuticals Inc's COVID-19 antibody therapy, an experimental treatment…
Regeneron antibodies in demand after Trump treatment
Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated last week with an…